NCT05551013 Treatment of Recurrent GBM With APG-157 Via Expanded Access Status NO_LONGER_AVAILABLE Phase N/A
NCT05541042 Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers Status NOT_YET_RECRUITING Phase N/A
NCT05538572 A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT05515133 Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients Status NOT_YET_RECRUITING Phase N/A
NCT05512195 Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma Status UNKNOWN Phase NA
NCT05502991 Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma Status NOT_YET_RECRUITING Phase PHASE2
NCT05450744 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) Status RECRUITING Phase PHASE1
NCT05439278 Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma Status RECRUITING Phase PHASE3
NCT05410301 Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma Status WITHDRAWN Phase NA
NCT05383872 Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors Status COMPLETED Phase NA
NCT05376800 A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma Status COMPLETED Phase PHASE1
NCT05375318 BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels Status COMPLETED Phase N/A
NCT05353530 IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1